Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Nov;41(5):263-75.
doi: 10.1677/JME-08-0103. Epub 2008 Sep 4.

Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways

Stephen Safe  1 , Kyounghyun Kim
Affiliations
Review

Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways

Stephen Safe et al. J Mol Endocrinol. 2008 Nov.

Erratum in

  • J Mol Endocrinol. 2009 Apr;42(4):359. Kim, Kyoungkim [corrected to Kim, Kyounghyun]

Abstract

17beta-estradiol binds to the estrogen receptor (ER) to activate gene expression or repression and this involves both genomic (nuclear) and non-genomic (extranuclear) pathways. Genomic pathways include the classical interactions of ligand-bound ER dimers with estrogen-responsive elements in target gene promoters. ER-dependent activation of gene expression also involves DNA-bound ER that subsequently interacts with other DNA-bound transcriptions factors and direct ER-transcription factor (protein-protein) interactions where ER does not bind promoter DNA. Ligand-induced activation of ER/specificity protein (Sp) and ER/activating protein-1 [(AP-1); consisting of jun/fos] complexes are important pathways for modulating expression of a large number of genes. This review summarizes some of the characteristics of ER/Sp- and ER/AP-1-mediated transactivation, which are dependent on ligand structure, cell context, ER-subtype (ERalpha and ERbeta), and Sp protein (SP1, SP3, and SP4) and demonstrates that this non-classical genomic pathway is also functional in vivo.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A summary of E2-responsive genes containing functional GC-rich & ERE1/2 motifs. There is evidence that formation of this complex may contain other proteins.
Figure 2
Figure 2
Hormonal activation of cyclin D1, bcl-2, and c-Fos in breast cancer cells. In addition to GC-rich sites activated by ERα/Sp, E2-dependent activation of non-genomic cAMP/PKA (cyclin D1 and bcl-2) and MAPK/PI3K(c-Fos) pathways were also identified.
Figure 3
Figure 3
Multiple E2-responsive elements. The PADI4 and prolactin receptor genes contain E2-responsive GC-rich sites and other functional cis-element that contributed to E2-induced transactivation.
Figure 4
Figure 4
Different mechanisms of hormonal activation of E2F1 in MCF-7 cells and ZR-75 cells.
Figure 5
Figure 5
Mechanisms of E2-dependent downregulation and induction of VEGFR2 in MCF-7 and ZR-75 cells, respectively.
Figure 6
Figure 6
Wild-type and ERα variants and domains of ERα required for transactivation by E2 and structurally diverse estrogenic compounds in MCF-7 (—) and MDA-MB-231 (---) breast cancer cells.
Figure 7
Figure 7
Domains of ERα and ERβ required for ligand-dependent activation of ER/AP1 (i.e.deletion results in loss of activity) (104, 107) and comparisons with activation of ERα /Sp.
See this image and copyright information in PMC

References

    1. Ammendola R, Mesuraca M, Russo T, Cimino F. Sp1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues. Journal of Biological Chemistry. 1992;267:17944–17948. - PubMed
    1. Augereau P, Miralles F, Cavailles V, Gaudelet C, Parker M, Rochefort H. Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Molecular Endocrinology. 1994;8:693–703. - PubMed
    1. Bardin A, Moll F, Margueron R, Delfour C, Chu ML, Maudelonde T, Cavailles V, Pujol P. Transcriptional and posttranscriptional regulation of fibulin-1 by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells. Endocrinology. 2005;146:760–768. - PubMed
    1. Barkhem T, Haldosen LA, Gustafsson JA, Nilsson S. pS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor α, an estrogen-responsive element, and the activator protein 1 response element. Molecular Pharmacology. 2002;61:1273–1283. - PubMed
    1. de Medeiros SR Batistuzzo, Krey G, Hihi AK, Wahli W. Functional interactions between the estrogen receptor and the transcription activator Sp1 regulate the estrogen-dependent transcriptional activity of the vitellogenin A1 io promoter. Journal of Biological Chemistry. 1997;272:18250–18260. - PubMed

Publication types